Grants & Contracts


Lenhard J (PI on sub-award for a NIH RO1 Grant), ($46,975). Individualized Therapeutic Strategies for Polymyxins: Targeting Gram-negative Superbugs with Maximal Precision. Submitted to NIH in March of 2018. 



Vinall R (PI), NIH P20 Grant ($703,955).  1/2 Pharmacists and Cancer researchers Together: the CNUCOP-UCD PACT. Submitted in January of 2017.

Woldemariam T (PI), Talbott G, Fitzpatrick LR ($5,000).  Screening of Plants as a Source of Anti-Inflammatory Agents for Treating Inflammatory Bowel Disease. Submitted to The Herb Society of America in January of 2017. 

Fitzpatrick LR (PI), Talbott G ($2,200).  NIH Phase 2 SBIR grant to Visionary Pharmaceuticals. PI on subcontract. Colonic Histology Evaluations Related to the Effects of a ROR-γ T Inhibitor on Mice with Innate Immune Colitis (Award occurred in June of 2017).             

Jin Z (PI), NIH RO1 Grant ($1,375,000).  Epigenetic Regulation of Regulatory T cell S1P/S1P1 Axis in Pathogenesis of Cardiac Fibrosis. Submitted in June of 2017.

Ho L (PI), ($7500). Role of Sirtuin-3 Mediated Changes in Adipogenesis in Type-2 Diabetes.  Submitted to International Pharmaceutical Excipients Council of the Americas Foundation in June of 2017.

Lenhard J (PI), ($10,000). Antimicrobial Pharmacodynamics against Co-cultured HAP and VAP Pathogens. Submitted to AACP (New Investigator Award) in August of 2017.


Ho L (PI), ($10,000). Anti-diabetogenic Role of a Sirtuin-3-Adinopectin Axis in Adipocytes. Submitted to AACP (New Investigator Award) in August of 2017.

California Northstate University College of Pharmacy ♦ 9700 West Taron Drive ♦ Elk Grove, CA 95757 ♦ Phone: (916) 686-7400

CNSU logo


Contact Us